Table 1.
Biochemical parameters.
| Before | Placebo 3 h | P value | Before | Cerivastatin 3 h | P value | |
|---|---|---|---|---|---|---|
| TC, (mg dl−1) | 189.2 ± 22.8 | 184.2 ± 31.3 | NS | 182.4 ± 22.4 | 179.8 ± 26.3 | NS |
| LDLC, (mg dl−1) | 122.9 ± 30.0 | 118.7 ± 26.0 | NS | 114.4 ± 22.0 | 123.2 ± 35.6 | NS |
| HDLC, (mg dl−1) | 61.0 ± 12.9 | 60.4 ± 14.9 | NS | 59.0 ± 14.0 | 59.0 ± 14.2 | NS |
| TG, (mg dl−1) | 98.8 ± 80.1 | 90.0 ± 54.2 | NS | 106.2 ± 126.3 | 74.9 ± 45.4 | NS |
| MDA-LDL, (Ul−1) | 86.7 ± 29.5 | 85.4 ± 33.9 | NS | 81.6 ± 33.7 | 88.9 ± 31.4 | NS |
| hsCRP, (ng ml−1) | 456.2 ± 389.1 | 437.2 ± 248.0 | NS | 456.6 ± 390.0 | 466.4 ± 315.1 | NS |
Values are mean ± s.d. TC indicates total cholesterol; LDLC, low-density lipoprotein cholesterol; HDLC, high-density lipoprotein cholesterol; TG, triglyceride; MDA-LDL, malondialdehyde-modified low-density lipoprotein; hsCRP, high sensitivity C-reactive protein.